{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:35:18Z","timestamp":1772606118505,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001335"],"award-info":[{"award-number":["82001335"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071410"],"award-info":[{"award-number":["82071410"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2022YFC3501303"],"award-info":[{"award-number":["2022YFC3501303"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2022YFC3501305"],"award-info":[{"award-number":["2022YFC3501305"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.clim.2023.109879","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T12:15:31Z","timestamp":1703247331000},"page":"109879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Clinical outcome and peripheral immune profile of myasthenic crisis with omicron infections: A prospective cohort study"],"prefix":"10.1016","volume":"259","author":[{"given":"Xiao","family":"Huan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huahua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yafang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoqin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianying","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangyu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2023.109879_bb0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1474-4422(21)00357-4","article-title":"Advances in the understanding of disease mechanisms of autoimmune neuromuscular junction disorders","volume":"21","author":"Huijbers","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2023.109879_bb0010","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","article-title":"Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders","volume":"21","author":"Punga","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2023.109879_bb0015","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.48.5.1253","article-title":"Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation","volume":"48","author":"Thomas","year":"1997","journal-title":"Neurology."},{"key":"10.1016\/j.clim.2023.109879_bb0020","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1212\/WNL.0000000000008688","article-title":"For the German Myasthenic crisis study group, Myasthenic crisis demanding mechanical ventilation: a multicenter analysis of 250 cases","volume":"94","author":"Neumann","year":"2020","journal-title":"Neurology."},{"key":"10.1016\/j.clim.2023.109879_bb0025","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1212\/WNL.0b013e31821e5505","article-title":"Comparison of IVIg and PLEX in patients with myasthenia gravis","volume":"76","author":"Barth","year":"2011","journal-title":"Neurology."},{"key":"10.1016\/j.clim.2023.109879_bb0030","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mus.23626","article-title":"Safety of plasma exchange therapy in patients with myasthenia gravis","volume":"47","author":"Ebadi","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clim.2023.109879_bb0035","article-title":"Real-world healthcare resource utilization and cost burden assessment for adults with generalized myasthenia gravis in the United States","volume":"12","author":"Phillips","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clim.2023.109879_bb0040","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41591-023-02241-7","article-title":"Determinants of COVID-19 vaccination status and hesitancy among older adults in China","volume":"29","author":"Wang","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2023.109879_bb0045","first-page":"315","article-title":"COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study","volume":"87","author":"Whitaker","year":"2023","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.clim.2023.109879_bb0050","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/annrheumdis-2020-219517","article-title":"OpenSAFELY collaborative, use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts","volume":"80","author":"Wong","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2023.109879_bb0055","doi-asserted-by":"crossref","first-page":"rkad064","DOI":"10.1093\/rap\/rkad064","article-title":"Antibody responses following the surge of SARS-CoV-2 omicron infection among patients with systemic autoimmune rheumatic diseases","volume":"7","author":"Xiang","year":"2023","journal-title":"Rheumatol. Adv. Pract."},{"key":"10.1016\/j.clim.2023.109879_bb0060","article-title":"Persistence of SARS-CoV-2 neutralizing antibodies and anti-omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: an explanatory study in Japan","volume":"32","author":"Yamaguchi","year":"2023","journal-title":"Lancet Reg. Health West Pac."},{"key":"10.1016\/j.clim.2023.109879_bb0065","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s10072-021-05823-w","article-title":"Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review","volume":"43","author":"Rodrigues","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.clim.2023.109879_bb0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41392-022-00997-x","article-title":"SARS-CoV-2 omicron variant: recent progress and future perspectives","volume":"7","author":"Fan","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.clim.2023.109879_bb0075","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/acn3.51312","article-title":"In-depth peripheral CD4 + T profile correlates with myasthenic crisis","volume":"8","author":"Huan","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.clim.2023.109879_bb0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jmv.27292","article-title":"Autoimmune complications of COVID-19","volume":"94","author":"Yazdanpanah","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.clim.2023.109879_bb0085","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12916-023-03049-5","article-title":"Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care","volume":"21","author":"Syed","year":"2023","journal-title":"BMC Med."},{"key":"10.1016\/j.clim.2023.109879_bb0090","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S1474-4422(20)30413-0","article-title":"CARE-MG study group, COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)","volume":"19","author":"Muppidi","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2023.109879_bb0095","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.9834","article-title":"Outcomes of COVID-19 infection and vaccination among individuals with myasthenia gravis","volume":"6","author":"Alcantara","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.clim.2023.109879_bb0100","doi-asserted-by":"crossref","first-page":"eadf8161","DOI":"10.1126\/sciimmunol.adf8161","article-title":"Exposure to lung-migrating helminth protects against murine SARS-CoV-2 infection through macrophage-dependent T cell activation","volume":"8","author":"Oyesola","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.clim.2023.109879_bb0105","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1126\/science.279.5355.1344","article-title":"Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection","volume":"279","author":"Zhao","year":"1998","journal-title":"Science."},{"key":"10.1016\/j.clim.2023.109879_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41421-020-0168-9","article-title":"Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing","volume":"6","author":"Wen","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.clim.2023.109879_bb0115","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11684-020-0824-3","article-title":"Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial","volume":"15","author":"Wang","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.clim.2023.109879_bb0120","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejca.2020.08.013","article-title":"Immunological features of coronavirus disease 2019 in patients with cancer","volume":"139","author":"Thibaudin","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.clim.2023.109879_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2141","article-title":"Interleukin-6 in Covid-19: a systematic review and meta-analysis","volume":"30","author":"Coomes","year":"2020","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.clim.2023.109879_bb0130","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s00134-021-06507-x","article-title":"Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial","volume":"47","author":"Rosas","year":"2021","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.clim.2023.109879_bb0135","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2023.109879_bb0140","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/CCM.0000000000005229","article-title":"Prognostic and predictive biomarkers in patients with Coronavirus Disease 2019 treated with tocilizumab in a randomized controlled trial","volume":"50","author":"Tom","year":"2022","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.clim.2023.109879_bb0145","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.cmi.2022.02.027","article-title":"Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM-a prospective, randomized, single-centre, open-label study","volume":"28","author":"Broman","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.clim.2023.109879_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-014-0179-6","article-title":"IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis","volume":"3","author":"Maurer","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.clim.2023.109879_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577634","article-title":"High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis","volume":"358","author":"Uzawa","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2023.109879_bb0160","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaut.2010.12.001","article-title":"Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis","volume":"36","author":"Aricha","year":"2011","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2023.109879_bb0165","article-title":"Responsiveness to tocilizumab in anti-acetylcholine receptor-positive generalized myasthenia gravis","author":"Jia","year":"2023","journal-title":"Aging Dis."},{"key":"10.1016\/j.clim.2023.109879_bb0170","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-023-06769-4","article-title":"Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases","author":"Papagoras","year":"2023","journal-title":"Clin. Rheumatol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623006435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623006435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:38:31Z","timestamp":1762547911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661623006435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":34,"alternative-id":["S1521661623006435"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2023.109879","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcome and peripheral immune profile of myasthenic crisis with omicron infections: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2023.109879","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109879"}}